Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kartik Singhal

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
JCO Precision Oncology|October 12, 2023
Donor-Derived Follicular Lymphoma After Kidney Transplantation: A Case ReportKartik Singhal, Marcus P Watkins, Todd A Fehniger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2026
NT-I7, a long-acting interleukin-7, increases lymphocyte counts and induces CD8+ T cell clonotype expansion in patients with newly diagnosed high-grade gliomasOmar H Butt, Kartik Singhal, Jingqin Luo, et al.
Arxiv|July 3, 2026
pVACtools v6: A comprehensive suite for neoantigen prediction, visualization, and therapy designMy H Hoang, Susanna Kiwala, Megan Richters, et al.
Cancer Cell|September 8, 2025
Large B cell lymphoma microenvironment archetype profilesXubin Li, Kartik Singhal, Qing Deng, et al.
Genome Medicine|November 14, 2024
Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patientsXiuli Zhang, S Peter Goedegebuure, Michael Y Chen, et al.
Blood Advances|May 7, 2024
Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphomaCody A Ramirez, Michelle Becker-Hapak, Kartik Singhal, et al.
Arxiv|December 19, 2025
ImmunoNX: a robust bioinformatics workflow to support personalized neoantigen vaccine trialsKartik Singhal, Evelyn Schmidt, Susanna Kiwala, et al.
Nucleic Acids Research|November 14, 2022
CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebaseKilannin Krysiak, Arpad M Danos, Jason Saliba, et al.
Nature|June 17, 2026
A 98-qubit trapped-ion quantum computer with all-to-all connectivityAnthony Ransford, M S Allman, Jake Arkinstall, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
JCO Precision Oncology|October 12, 2023
Donor-Derived Follicular Lymphoma After Kidney Transplantation: A Case ReportKartik Singhal, Marcus P Watkins, Todd A Fehniger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2026
NT-I7, a long-acting interleukin-7, increases lymphocyte counts and induces CD8+ T cell clonotype expansion in patients with newly diagnosed high-grade gliomasOmar H Butt, Kartik Singhal, Jingqin Luo, et al.
Arxiv|July 3, 2026
pVACtools v6: A comprehensive suite for neoantigen prediction, visualization, and therapy designMy H Hoang, Susanna Kiwala, Megan Richters, et al.
Cancer Cell|September 8, 2025
Large B cell lymphoma microenvironment archetype profilesXubin Li, Kartik Singhal, Qing Deng, et al.
Genome Medicine|November 14, 2024
Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patientsXiuli Zhang, S Peter Goedegebuure, Michael Y Chen, et al.
Blood Advances|May 7, 2024
Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphomaCody A Ramirez, Michelle Becker-Hapak, Kartik Singhal, et al.
Arxiv|December 19, 2025
ImmunoNX: a robust bioinformatics workflow to support personalized neoantigen vaccine trialsKartik Singhal, Evelyn Schmidt, Susanna Kiwala, et al.
Nucleic Acids Research|November 14, 2022
CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebaseKilannin Krysiak, Arpad M Danos, Jason Saliba, et al.
Nature|June 17, 2026
A 98-qubit trapped-ion quantum computer with all-to-all connectivityAnthony Ransford, M S Allman, Jake Arkinstall, et al.
Pageof 1